• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Rexahn & BioSense Enter License Agreement contractpharma
    April 17, 2019
    To advance the development and commercialization of RX-3117 for pancreatic cancer and other cancers in Greater China...
  • Rexahn, Merck Partner for Cancer contractpharma
    August 22, 2018
    Rexahn Pharmaceuticals has entered into a clinical trial collaboration agreement with Merck to evaluate the combination of Rexahn’s RX-5902 and Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab) in a Phase 2 trial in patients with metastatic triple nega
  • Rexahn, Haichang collaborate for developing liver cancer treatment biospectrumasia
    February 11, 2018
    Any clinical trials conducted by Haichang will be designed to meet both U.S. and Chinese regulatory requirements.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service